Browse All

Current Filters

CLEAR FILTER x

TITLE

Safety, Tolerability, and Pharmacokinetics of BHV-2100, a First-in-class TRPM3 Antagonist for Pain and Migraine

Author:Granit, Volkan   Bertz, Richard   Lucas, Andrew   Ashbrenner, Eric   Donohue, Mary   Mydlow, Patricia   Jensen, Christopher   Vriens, Joris   Voets, Thomas   Emerson, Beth   Qureshi, Irfan   Coric, Vladimir   

Session Name:S11: Pain  

Topic:Pain  

Program Number:S11.004  

Author Institution:Biohaven, New Haven, CT  PumasAI, Dover, DE  Biohaven, Kaukauna, WI  Mydlow Consulting, LCC, Durham, NC  Laboratory of Ion Channel Research, KU Leuven, Leuven, Belgium  VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium  

BHV-2100, a First-in-Class TRPM3 Antagonist in Development for the Treatment of Migraine

Author:Emerson, Beth   Pieters, Anne   Morris, Beth   Lucas, Andrew   Granit, Volkan   Jensen, Christopher   Vriens, Joris   Voets, Thomas   Qureshi, Irfan   Coric, Vladimir   Lipton, Richard   

Session Name:P7: Headache: Advances in Headache Treatment 1  

Topic:Headache  

Program Number:P7.009  

Author Institution:Biohaven, New Haven, CT  PumasAI, Dover, DE  Biohaven, Miami, FL  Laboratory of Ion Channel Research, KU Leuven, Leuven, Belgium  VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium